Global Bone Growth Stimulators Strategic Business Report 2024: Market expected to reach $1.5 billion by 2030 from $1.1 billion in 2022

Bone growth stimulator market

DUBLIN, February 15, 2024 (Globe Newswire) — The 'Bone Growth Stimulators – Global Strategic Business Report' report has been added. ResearchAndMarkets.com Recruitment.

Global bone growth stimulator market expected to reach $1.5 billion by 2030

The global market for bone growth stimulators, estimated at USD 1.1 billion in 2022, is projected to reach a revised size of USD 1.5 billion by 2030, growing by 4.7% over the analysis period 2022-2030. growing at a CAGR of Stimulation devices, one of the segments analyzed in the report, is projected to register a CAGR of 4.8% and reach USD 855.7 million by the end of the analysis period. The growth of the bone morphogenetic protein (BMP) segment is estimated at a CAGR of 4.4% over the next eight years.

The US market is estimated at $544 million, while China is projected to grow at a CAGR of 6.6%

The US bone growth stimulator market is estimated to be USD 544 million in 2022. China, the world's second largest economy, is expected to reach a projected market size of USD 109.1 million by 2030, maintaining a CAGR of 6.6% YoY. The analysis period is from 2022 to 2030. Other notable geographic markets include Japan and Canada, which are expected to grow by 3.8% and 4%, respectively, over the 2022-2030 period. Among Europe, Germany is projected to grow at a CAGR of approximately 4%.

What's new?

• Special discussion on global economic conditions and market sentiment

• Coverage on global competitiveness and market share percentage of major competitors

• Market Presence Analysis Across Multiple Regions – Strong/Active/Niche/Minor

• Tailor-made updates for online interactive peer-to-peer collaboration

• Access to a digital archive and trademarked research platform

• 1 year of free updates

• Access to selected YouTube video transcripts of market sentiment shared by CEOs, subject matter experts, and market influencers through interviews, podcasts, press statements, and event keynotes

Key attributes:

Market overview

story continues

• Bone Growth Stimulators – Global Major Competitors Market Share Percentage in 2022 (E)

• Competitive Market Presence – Strong/Active/Niche/Mediocre (E) for Players Worldwide in 2022

• New coronavirus infection casts a shadow on the normality of orthopedic surgery volume

• Number of elective orthopedic surgeries performed in the U.S.: April-June 2020 and April-June 2019

• Pandemic fears prompt hospitals to shift from inpatient to outpatient surgeries

• Bone Growth Stimulator: Introduction

• Types of bone growth stimulants

• Market overview and outlook

• Hospitals and Clinics: Key End-User Segments

• US maintains dominance in global bone growth stimulant market

• US FDA proposes subclassification of non-invasive bone growth stimulators

• competition

• Market share of key players in the global bone growth stimulator market: 2019

• Recent market activity

Market trends and drivers

• The increasing number of fractures and the increasing incidence of delayed union and nonunion fractures are increasing the demand for bone stimulators

• Osteoporosis and other bone-related health concerns: Fact sheet

• Hip fracture statistics

• Select musculoskeletal condition – percentage breakdown by age group

• Breakdown of the number of fractures by age group: 2019

• Increased vertebral fractures to promote growth

• Vertebral fracture statistics

• Increase in trauma incidents supports demand

• Increasing incidence of osteoporosis contributes to market growth

• Global Osteoporosis Prevalence: Millions of Osteoporosis Patients by Selected Countries/Regions in 2012 and 2022 P

• There are great opportunities for spinal fusion surgery

• US spinal fusion market: Breakdown of number of surgeries by age group

• Bone stimulator shows potential application in osteoarthritis treatment

• The role of platelet-rich plasma (PRP) as a bone growth stimulator

• Increase in minimally invasive and robotic surgery raises prospects

• Global Surgical Robot Market by Surgery Type: 2019

• Advances in implant technology will increase the number of surgeries, supporting demand for bone stimulators

• Demographic factors driving growth

• Obesity epidemic rate

• Global obesity epidemic: Percentage of adults who are overweight, obese, and severely obese in 2014 and 2025

• Average annual per capita health expenditure due to obesity (US$)

• Obesity prevalence (%) in selected countries in 2019 and 2030P

• Diabetes incidence reaches alarming levels, increasing risk of impaired fracture healing and benefiting demand

• Global diabetes and demographics (2019, 2030, 2045)

• World diabetes prevalence (2000-2045P)

• Aging population and vulnerability to various diseases and disorders related to bones and joints are driving healthy growth of the market

• World aging population statistics for age groups 65 years and older by geographic region in 2019, 2025, 2035 and 2050 (in million people)

• Table 19: World life expectancy at birth (years) by geographic region: 1950–2050

• Rising medical costs driving growth

• Global health spending 2017-2023 (US$ billion)

Focus on carefully selected players(62 total)

• AIDP Co., Ltd.

• Bioiberica SAU

• douglas institute

• Bioventus LLC

• depuy synth

• Hellenia Co., Ltd.

• Ist Biologics

• PRP America LLC Dr.

• M-Site Co., Ltd.

• Innofos Co., Ltd.

• Amway, Inc. – Nutrilite

• G&G vitamins

• isotonics

• Cellmed Co., Ltd.

• Grofin Oi

For more information on this report, please visit https://www.researchandmarkets.com/r/8nt6ne.

About ResearchAndMarkets.com
ResearchAndMarkets.com is the world's leading source of international market research reports and market data. We provide the latest data on international and regional markets, key industries, top companies, new products and latest trends.

attachment

CONTACT: CONTACT: ResearchAndMarkets.com Laura Wood,Senior Press Manager [email protected] For E.S.T Office Hours Call 1-917-300-0470 For U.S./ CAN Toll Free Call 1-800-526-8630 For GMT Office Hours Call +353-1-416-8900